The study shows the benefit of nocturnal intraocular pressure measurements as well.
A study shows the procedure can also help manage uveitic glaucoma.
Disc hemorrhaging may be an important risk factor for the progression of glaucoma, researcher report.
Researchers identify racial differences in glaucomatous changes to the structure of the lamina cribrosa.
Researchers say cataract surgery patients with no macular pathology may benefit from IOP-controlling medication.
The research also suggests investigations can consider fewer than 300 participants.
The topical medication is appropriate for long-term use, the report shows.
Instances of infection are rare but surgeons must be aware of the link, the study says.
Study shows the refractive status can lead to disease progression for glaucoma suspects.
The study evaluated how the glaucoma treatment affects the corneal using data from a randomized, phase 3 study.
Researchers confirmed the lasting effect of a biodegradable, intracameral implant.
The study also explored complication rates of the laser procedure.
David Richardson, MD, of San Marino Eye explains an approach to glaucoma care that maintains the eye’s drainage system, rather than destroys it.
Researchers compared the treatment effect of rAAV2/2-ND4 with an external control group of untreated patients.
Elongated sinusoidal stimulus demonstrates a good structure-function agreement, a study shows.
Case series was developed to evaluate 24-month efficacy of the viscodilation of Schlemm’s canal and the distal outflow system using the device.
Researchers relied on data from the Ocular Hypertension Study to determine the 20-year cumulative incidence of POAG, and the cumulative incidence of visual field loss.
Researchers identified particular disparities in health screenings across Africa and Asia.
Researchers reviewed the corneal impacts of various intraocular pressure lowering therapies.
Clinicians should consider myopia progression a red flag in juvenile patients with glaucoma.